Page 150breast, kidney, and uterus, as well as leukemia, Hodgkin’s and other cancers,
during the 1970’s—just using fasting. You can read about it on my website.
Well, Kobyashi followed several immune signaling substances, including one
group called the cyclic nucleotides; we know those are powerful and positive
regulators of the immune system and help it eliminate cancer cells just as soon
as they form. These are found in all living cells. The cyclic nucleotides, according
to Kobayashi, were favorably increased by fasting, adoptive immune (sensitized
lymphocyte) therapy, and their combination.
Through interpreters, we know that Dr. Kobayashi has kept approximately 15,000
patients cancer-free over an 18 year duration, by implementing primarily natural
methods of treatment during stages IV & V.
We now have to wait for this success program to filter through and become
gradually adopted. My friend Dr Garry Gordon in Phoenix is working closely with
Kobayashi and hopes to bring his methods here to the Western US.
I for one look forward to seeing their impact on conventional thinking.
Finally, a hot new item. Keep your eye on MicroRNA.
Say what?
RNA (ribonucleic acid) is the twin brother of DNA (deoxy-ribonucleic acid).
It’s the one which copies and translates, remember? Micro RNA means just
short strips of RNA, like strips of yarn, instead of the whole ball. MicroRNA has
emerged as a hot new marker for tumors, starting with the lethal pancreatic
cancer.
Remember, you read it here first!
MicroRNA may even and may even be able to predict long- and short-term
survival, according to an article in the May 2, 2007 issue of the Journal of the
American Medical Association.
Researchers were able to distinguish pancreatic cancer from normal pancreas
in 90% of cases and, separately, from chronic pancreatitis in 93% of cases. A
particular microRNA, if present, showed up patients who would likely survive
longer than 24 months, compared with those who survived less.
All this was to a high degree of accuracy: in the 90% range.